Systemic_lupus_erythmatosus

  • Uploaded by: mara5140
  • 0
  • 0
  • December 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Systemic_lupus_erythmatosus as PDF for free.

More details

  • Words: 666
  • Pages: 25
Nursing Care of the Client with Connective Tissue Disease Systemic

Lupus Systemic Sclerosis Polymyositis

Systemic Lupus Erythmatosus Multisystem Inflammatory Disease

Etiology and Pathophysiology 

Etiology – unknown  Genetic

predisposition  Hormones  Environmental factors  Triggers: Infection  Certain medications 

Overaggressive Antibody Response 

Immune complexes deposited in basement membranes of capillaries:  Kidneys  Heart  Skin  Brain  Joints

* Specific symptoms of SLE depend on which cells or organs are involved

Manifestations & Complications   

Variable depending on severity Any organ(s) may be affected Most commonly affected:  Skin  Muscle  Lungs  Heart  Nervous  Kidneys

system

Manifestations & Complications 

Skin   



Musculoskeletal  



Butterfly rash – 50% of patients Ulcers – mouth or nose Alopecia Polyarthralgia – 90% of patients Non-erosive arthritis

Cardiopulmonary   

Tachypnea & cough Arrhythmias Accelerates CAD

Manifestations & Complications 

Renal problems – 50% of clients within one year 



Mild proteinuria to glomerulonephritis

Nervous system      

Seizures Disordered thought processes Disorientation Memory deficits Depression Psychosis

Manifestations & Complications 

Hematological problems  Anemia  Mild

leukopenia  Thrombocytopenia 

Infection  Immunosuppresive

effect of anti-

inflammatory drugs  Defects in ability to phagocytize invading bacteria

Diagnosis of SLE  





No specific diagnostic test Four or more of criteria are present serially or simultaneously Presence of criteria are not definitive for diagnosis “rule-out” other disease processes

Drug Therapy   

 

NSAID’s hydroxychloroquine (Plaquenil) corticosteroids – especially during severe exacerbations of polyarthritis methotrexate azathioprine (Imuran)

Nursing Care 



Assess severity of symptoms: fever, joint pain and limitations of movement, fatigability Weight and I&O – risk of fluid overload:  renal

failure  corticosteroid therapy

Nursing Care 

Observe S/S bleeding     



Changes in vital signs Bruising Petechiae Tarry stools Pallor

Assess neuro status    

Visual disturbances Mental status Seizures Numbness, tingling, weakness of extremities

Patient Education 

 



Avoid triggers: sun, infections, emotional stress, etc. Pre-conception counseling Correct use of medication(s) and importance of compliance Disease complications are “hidden”; physical limitations are not obvious

Patient Education Web site co-sponsored by NIH and National Institute of Arthritis and Musculoskeletal and Skin Diseases

http://www.niams.nih.gov/hi/topics/lupus

Systemic Sclerosis    

Fibrotic, degenerative changes Skin thickening/tightening Localized vs. systemic Causes:  Immune

dysfunction  Vascular abnormalities  Environmental exposure

Systemic Sclerosis  

Collagen is over produced CREST syndrome:  Calcinosis  Raynaud’s

phenomenon  Esophageal dysfunction  Sclerodactyly  Telangiectasia

Systemic Sclerosis 

Internal organ involvement  Esophageal

fibrosis  Lung involvement  Heart disease (CHF)  Kidney disease with malignant hypertension

Nursing and Collaborative Care 

Goal of medical regimen:  Prevent

complications of involved

organs  Medications:

Corticosteroids  Vasodilators (Raynaud’s, hypertension)  H2 receptor blocker or proton pump inhibitor (GI symptoms) 

 

Physical therapy Nursing care

Nursing Care 

Assessment:  Joint

ROM  Respiratory function  Nutrition: swallowing, weight, I&O  Circulation: Raynaud’s  Body image

Nursing Care 

Nursing Interventions:  ROM

exercises, mouth excursion  Moist heat/parafifin  Protect hands and feet: Keep warm  Gloves  No finger-stick blood testing  No smoking – vasoconstriction  Inspect for injury/infection 

Nursing Care  

Special attention to oral care Nutrition and hydration  Small,

frequent meals  Carefull/complete chewing  Dysphagia precautions Thickened liquids  High fowlers 2 hours after eating 

 Antacids

45 minutes after eating if gastric reflux

Resources for clients and health professionals http://www.scleroderma.org/

Polymyositis 

 



Diffuse, inflammatory myopathies of striated muscle Relatively rare Produces bilateral weakness of shoulders, legs, arms and pelvic girdle Joint pain, reddness, inflammation

Collaborative Care 

Patient teaching:      

  

Prescribed therapies Tests Importance of follow-up care Delay in response to therapy Patient safety Paced activity

Physical therapy High-dose corticosteroids Immunosuppressive drugs 

methotrexate

More Documents from "mara5140"

Icp_head Trauma
December 2019 17
Immune_responses
December 2019 20
Cancer Intro
December 2019 15
Systemic_lupus_erythmatosus
December 2019 11
Cv Patho[1]
December 2019 20